Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Mineralys First Quarter 2024 Earnings Conference Call. At this time all lines are in listen-only mode.
Mineralys Therapeutics Inc. (MLYS)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.50 | 555,555 | 5,074,916 | 2024-02-12 | Filing | ||
| $5.97 | 4,250 | Officer, Director | 1,049,068 | 2023-11-22 | Filing | |
| $12.08 | 2,250 | Officer, Director | 1,044,818 | 2023-09-06 | Filing | |
| $12.10 | 2,250 | Officer, Director | 1,042,568 | 2023-08-17 | Filing | |
| $12.89 | 2,000 | Officer, Director | 1,040,318 | 2023-08-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.73 | 14,940 | Officer, Director | 926,958 | 2024-06-20 | Filing | |
| $11.99 | 16,607 | Officer, Director | 941,898 | 2024-06-18 | Filing | |
| $12.25 | 17,766 | Officer, Director | 958,505 | 2024-06-17 | Filing | |
| $12.52 | 16,229 | Officer, Director | 976,271 | 2024-06-14 | Filing | |
| $12.74 | 39,961 | Officer, Director | 992,500 | 2024-06-13 | Filing |
News See All
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript
Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.61, expectations were $-0.85.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Mineralys Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions].
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Mineralys Second Quarter 2023 Earnings Call [Operator Instructions]. As a reminder, this conference is being recorded.
Hedge Fund and Insider Trading News: Christopher Hohn, Ray Dalio, Galois Capital, Bain Capital, Elliott Management, Point72 Asset Management, Mineralys Therapeutics Inc (MLYS), Impinj, Inc. (PI), and More
When Ray Dalio, the multibillionaire founder of the world’s biggest hedge fund, Bridgewater Associates, announced his retirement in October, both he and the firm he founded more than four decades ago...
Billionaire Hedge Funds
